However, our data show that SARM1 activation is sufficient to drive degeneration of multiple types of retinal neuron (including RGC) in addition to photoreceptors (Sasaki et al., 2020b), making SARM1 a promising target to treat retinal degeneration, at least in response to certain insults. This evidence concerns the gene SARM1 and retinal degeneration.